High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: A 3-year prospective study in China

被引:109
作者
Li, Huating [1 ,2 ]
Dong, Kun [1 ,2 ]
Fang, Qichen [1 ]
Hou, Xuhong [1 ]
Zhou, Mi [1 ,2 ]
Bao, Yuqian [1 ]
Xiang, Kunsan [1 ]
Xu, Aimin [3 ,4 ]
Jia, Weiping [1 ]
机构
[1] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai Diabet Inst,Shanghai Clin Ctr Diabet, Shanghai 200233, Peoples R China
[2] Shanghai Jiao Tong Univ, Dept Med, Sch Med, Shanghai 200233, Peoples R China
[3] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China
[4] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China
关键词
FGF21; NAFLD; Predictor; METABOLIC SYNDROME; FGF21; LEVELS; OBESITY; POPULATION; FGF-21; INDEX; MODE;
D O I
10.1016/j.jhep.2012.10.029
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Fibroblast growth factor 21 (FGF21), a hormone predominantly secreted by the liver, has been shown to be positively associated with the severity of non-alcoholic fatty liver disease (NAFLD) in cross-sectional studies. We investigated the prospective association of FGF21 with NAFLD development in a 3-year prospective study involving a population-based cohort comprising 808 Chinese subjects. Methods: Serum FGF21 levels at baseline and follow-up were measured using an enzyme-linked immunosorbent assay. Independent predictors of NAFLD development were identified using multiple logistic regressions. The predicting accuracy of the models was evaluated using area under the receiver-operating characteristic (ROC) curves (AUCs). Results: In subjects who had progressed to NAFLD, the baseline FGF21 concentration (319.12 pg/ml [172.65, 518.78]) was significantly higher than that in subjects who did not develop NAFLD (199.10 pg/ml [123.56, 322.80]) (p <0.001). At follow-up, significant increase of FGF21 level was observed in those subjects who developed NAFLD (p <0.05). Baseline FGF21 was an independent predictor of NAFLD (OR: 7.102 [95% CI 2.488-20.270]; p <0.001), together with body mass index (BMI) (OR: 1.489 [95% CI 1.310-1.691]; p <0.001). The ROC-AUC was 0.816 (95% CI 0.766-0.867) for the FGF21 Model, which was calculated with FGF21 and BMI. FGF21 Model <0.13 can be used to rule out (sensitivity = 85.71%, negative likelihood ratio = 0.23) and >= 0.30 can be rule in (specificity = 86.34%, positive likelihood ratio = 3.66) ultrasonography-diagnosed NAFLD after 3 years. Conclusions: High serum FGF21 concentration was an independent predictor of NAFLD in humans. The FGF21 Model and its cut-offs may be useful for early diagnosis and intervention of NAFLD. (C) 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:557 / 563
页数:7
相关论文
共 29 条
[1]  
Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390
[2]   Fibroblast Growth Factor 21-Deficient Mice Demonstrate Impaired Adaptation to Ketosis [J].
Badman, Michael K. ;
Koester, Anja ;
Flier, Jeffrey S. ;
Kharitonenkov, Alexei ;
Maratos-Flier, Eleftheria .
ENDOCRINOLOGY, 2009, 150 (11) :4931-4940
[3]   The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population [J].
Bedogni, Giorgio ;
Bellentani, Stefano ;
Miglioli, Lucia ;
Masutti, Flora ;
Passalacqua, Marilena ;
Castiglione, Anna ;
Tiribelli, Claudio .
BMC GASTROENTEROLOGY, 2006, 6 (1)
[4]  
Bobbert T, 2012, DIABETES CARE
[5]   Fatty Liver Index and Mortality: The Cremona Study in the 15th Year of Follow-Up [J].
Calori, Giliola ;
Lattuada, Guido ;
Ragogna, Francesca ;
Garancini, Maria Paola ;
Crosignani, Paolo ;
Villa, Marco ;
Bosi, Emanuele ;
Ruotolo, Giacomo ;
Piemonti, Lorenzo ;
Perseghin, Gianluca .
HEPATOLOGY, 2011, 54 (01) :145-152
[6]   IS HEPATIC ULTRASONOGRAPHY A VALID ALTERNATIVE TOOL TO LIVER-BIOPSY - REPORT ON 507 CASES STUDIED WITH BOTH TECHNIQUES [J].
CELLE, G ;
SAVARINO, V ;
PICCIOTTO, A ;
MAGNOLIA, MR ;
SCALABRINI, P ;
DODERO, M .
DIGESTIVE DISEASES AND SCIENCES, 1988, 33 (04) :467-471
[7]   High Plasma Level of Fibroblast Growth Factor 21 Is an Independent Predictor of Type 2 Diabetes A 5.4-year population-based prospective study in Chinese subjects [J].
Chen, Cheng ;
Cheung, Bernard M. Y. ;
Tso, Annette W. K. ;
Wang, Yudong ;
Law, Lawrence S. C. ;
Ong, Kwok Leung ;
Wat, Nelson M. S. ;
Xu, Aimin ;
Lam, Karen S. L. .
DIABETES CARE, 2011, 34 (09) :2113-2115
[8]   Circulating FGF-21 levels in normal subjects and in newly diagnose patients with type 2 diabetes Mellitus [J].
Chen, W. -W. ;
Li, L. ;
Yang, G. -Y. ;
Li, K. ;
Qi, X. -Y. ;
Zhu, W. ;
Tang, Y. ;
Liu, H. ;
Boden, G. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2008, 116 (01) :65-68
[9]   Non-alcoholic fatty liver disease in the Asia-Pacific region: Definitions and overview of proposed guidelines [J].
Chitturi, Shivakumar ;
Farrell, Geoffrey C. ;
Hashimoto, Etsuko ;
Saibara, Toshiji ;
Lau, George K. K. ;
Sollano, Jose D. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (06) :778-787
[10]   Fibroblast Growth Factor 21 Corrects Obesity in Mice [J].
Coskun, Tamer ;
Bina, Holly A. ;
Schneider, Michael A. ;
Dunbar, James D. ;
Hu, Charlie C. ;
Chen, Yanyun ;
Moller, David E. ;
Kharitonenkov, Alexei .
ENDOCRINOLOGY, 2008, 149 (12) :6018-6027